Bachmann, M.F., U. Kalinke, A. Althage, G. Freer, C. Burkhart, H. Roost, M. Aguet, H. Hengartner, and R.M. Zinkernagel. 1997. The role of antibody concentration and avidity in antiviral protection. Science. 276:2024–2027. doi:10.1126/science.276.5321.2024 Balázs, M., F. Martin, T. Zhou, and J. Kearney. 2002. Blood dendritic cells in­ teract with splenic marginal zone B cells to initiate T­ independent immune responses. Immunity. 17:341–352. doi:10.1016/S1074­ 7613(02)00389­ 8 Barr, T.A., S. Brown, G. Ryan, J. Zhao, and D. Gray. 2007. TLR­ mediated stimulation of APC: distinct cytokine responses of B cells and dendritic cells. Eur. J. Immunol. 37:3040–3053. doi:10.1002/eji.200636483 Barr, T.A., S. Brown, P. Mastroeni, and D. Gray. 2009. B cell intrinsic MyD88 signals drive IFN­ gamma production from T cells and control switching to IgG2c. J. Immunol. 183:1005–1012. doi:10.4049/jimmunol .0803706 Baumgarth, N., O.C. Herman, G.C. Jager, L. Brown, L.A. Herzenberg, and L.A. Herzenberg. 1999. Innate and acquired humoral immunities to in­ fluenza virus are mediated by distinct arms of the immune system. Proc. Natl. Acad. Sci. USA. 96:2250–2255. doi:10.1073/pnas.96.5.2250 Baumgarth, N., Y.S. Choi, K. Rothaeusler, Y. Yang, and L.A. Herzenberg. 2008. B cell lineage contributions to antiviral host responses. Curr. Top. Microbiol. Immunol. 319:41–61. doi:10.1007/978­ 3­ 540­ 73900­ 5_3 Baumhäckel, H., B. Liesegang, A. Radbruch, K. Rajewsky, and F. Sablitzky. 1982. Switch from NP­ specific IgG3 to IgG1 in the mouse hybridoma cell line S24/63/63. J. Immunol. 128:1217–1220. Belperron, A.A., C.M. Dailey, and L.K. Bockenstedt. 2005. Infection­ induced marginal zone B cell production of Borrelia hermsii­ specific anti­ body is impaired in the absence of CD1d. J. Immunol. 174:5681–5686. Belperron, A.A., C.M. Dailey, C.J. Booth, and L.K. Bockenstedt. 2007. Marginal zone B­ cell depletion impairs murine host defense against Borrelia burgdorferi infection. Infect. Immun. 75:3354–3360. doi:10.1128/ IAI.00422­ 07 Bendelac, A., M. Bonneville, and J.F. Kearney. 2001. Autoreactivity by design: innate B and T lymphocytes. Nat. Rev. Immunol. 1:177–186. doi:10.1038/35105052 Berberian, L., L. Goodglick, T.J. Kipps, and J. Braun. 1993. Immunoglobulin VH3 gene products: natural ligands for HIV gp120. Science. 261:1588– 1591. doi:10.1126/science.7690497 Blutt, S.E., S.E. Crawford, K.L. Warfield, D.E. Lewis, M.K. Estes, and M.E. Conner. 2004. The VP7 outer capsid protein of rotavirus in­ duces polyclonal B­cell activation. J. Virol. 78:6974–6981. doi:10.1128/ JVI.78.13.6974­6981.200 4 Bogdan, C. 2000. The function of type I interferons in antimicrobial immunity. Curr. Opin. Immunol. 12:419–424. doi:10.1016/S0952­ 7915(00)00111­ 4 Bothwell, A.L., M. Paskind, M. Reth, T. Imanishi­Kari, K. Rajewsky, and D. Baltimore. 1981. Heavy chain variable region contribution to the NPb family of antibodies: somatic mutation evident in a gamma 2a vari­ able region. Cell. 24:625–637. doi:10.1016/0092­8674(81)90089­ 1 Braun, D., I. Caramalho, and J. Demengeot. 2002. IFN­alpha/beta en ­ hances BCR­dependent B cell responses. Int. Immunol. 14:411–419. doi:10.1093/intimm/14.4.411 Chang, W.L., E.S. Coro, F.C. Rau, Y. Xiao, D.J. Erle, and N. Baumgarth. 2007. Influenza virus infection causes global respiratory tract B cell response modulation via innate immune signals. J. Immunol. 178:1457– 1467. Claassen, E., N. Kors, C.D. Dijkstra, and N. Van Rooijen. 1986. Marginal zone of the spleen and the development and localization of specific antibody­ forming cells against thymus­ dependent and thymus­ independent type­2 antigens. Immunology. 57:399–403. Coro, E.S., W.L. Chang, and N. Baumgarth. 2006. Type I IFN receptor signals directly stimulate local B cells early following influenza virus in­ fection. J. Immunol. 176:4343–4351. Coutelier, J.P., J.T. van der Logt, F.W. Heessen, G. Warnier, and J. Van Snick. 1987. IgG2a restriction of murine antibodies elicited by viral infections. J. Exp. Med. 165:64–69. doi:10.1084/jem.165.1.64 Coutinho, A., E. Gronowicz, W.W. Bullock, and G. Möller. 1974. Mecha­ nism of thymus­independent immunocyte triggering. Mitogenic activa­ tion of B cells results in specific immune responses. J. Exp. Med. 139: 74–92. doi:10.1084/jem.139.1.74 1498 Cumano, A., and K. Rajewsky. 1985. Structure of primary anti­(4­ hydroxy­3­nitrophenyl)acetyl (NP) antibodies in normal and idio ­ typically suppressed C57BL/6 mice. Eur. J. Immunol. 15:512–520. doi:10.1002/eji.1830150517 Cunningham, A.F., F. Gaspal, K. Serre, E. Mohr, I.R. Henderson, A. Scott­ Tucker, S.M. Kenny, M. Khan, K.M. Toellner, P.J. Lane, and I.C. MacLennan. 2007. Salmonella induces a switched antibody response without germinal centers that impedes the extracellular spread of infec­ tion. J. Immunol. 178:6200–6207. Eckl­ Dorna, J., and F.D. Batista. 2009. BCR­ mediated uptake of antigen linked to TLR9 ligand stimulates B­ cell proliferation and antigen­ specific plasma cell formation. Blood. 113:3969–3977. doi:10.1182/blood­ 2008­ 10­ 185421 Fagarasan, S., and T. Honjo. 2000. T­ Independent immune response: new aspects of B cell biology. Science. 290:89–92. doi:10.1126/science.290.5489.89 Fehr, T., H.Y. Naim, M.F. Bachmann, A.F. Ochsenbein, P. Spielhofer, E. Bucher, H. Hengartner, M.A. Billeter, and R.M. Zinkernagel. 1998. T­ cell independent IgM and enduring protective IgG anti­ bodies induced by chimeric measles viruses. Nat. Med. 4:945–948. doi:10.1038/nm0898­ 945 Finkelman, F.D., A. Svetic, I. Gresser, C. Snapper, J. Holmes, P.P. Trotta, I.M. Katona, and W.C. Gause. 1991. Regulation by interferon alpha of immunoglobulin isotype selection and lymphokine production in mice. J. Exp. Med. 174:1179–1188. doi:10.1084/jem.174.5.1179 García de Vinuesa, C., P. O’Leary, D.M. Sze, K.M. Toellner, and I.C. MacLennan. 1999. T­independent type 2 antigens induce B cell pro ­ liferation in multiple splenic sites, but exponential growth is confined to extrafollicular foci. Eur. J. Immunol. 29:1314–1323. doi:10.1002/ (SICI)1521­4141(199904)29:04<1314::AID­IMMU1314>3.0.CO;2­ 4 Gavin, A.L., K. Hoebe, B. Duong, T. Ota, C. Martin, B. Beutler, and D. Nemazee. 2006. Adjuvant­ enhanced antibody responses in the absence of toll­ like receptor signaling. Science. 314:1936–1938. doi:10.1126/ science.1135299 Genestier, L., M. Taillardet, P. Mondiere, H. Gheit, C. Bella, and T. Defrance. 2007. TLR agonists selectively promote terminal plasma cell differentiation of B cell subsets specialized in thymus­independent responses. J. Immunol. 178:7779–7786. Gitlin, L., W. Barchet, S. Gilfillan, M. Cella, B. Beutler, R.A. Flavell, M.S. Diamond, and M. Colonna. 2006. Essential role of mda­5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encepha­ lomyocarditis picornavirus. Proc. Natl. Acad. Sci. USA. 103:8459–8464. doi:10.1073/pnas.0603082103 Gorden, K.B., K.S. Gorski, S.J. Gibson, R.M. Kedl, W.C. Kieper, X. Qiu, M.A. Tomai, S.S. Alkan, and J.P. Vasilakos. 2005. Synthetic TLR ag­ onists reveal functional differences between human TLR7 and TLR8. J. Immunol. 174:1259–1268. Goud, S.N., N. Muthusamy, and B. Subbarao. 1988. Differential responses of B cells from the spleen and lymph node to TNP­Ficoll. J. Immunol. 140:2925–2930. Gray, D., I.C. MacLennan, H. Bazin, and M. Khan. 1982. Migrant mu+ delta+ and static mu+ delta­ B lymphocyte subsets. Eur. J. Immunol. 12:564–569. doi:10.1002/eji.1830120707 Green, N.M., A. Laws, K. Kiefer, L. Busconi, Y.M. Kim, M.M. Brinkmann, E.H. Trail, K. Yasuda, S.R. Christensen, M.J. Shlomchik, et al. 2009. Murine B cell response to TLR7 ligands depends on an IFN­ beta feedback loop. J. Immunol. 183:1569–1576. doi:10.4049/jimmunol.0803899 Guinamard, R., M. Okigaki, J. Schlessinger, and J.V. Ravetch. 2000. Absence of marginal zone B cells in Pyk­2­deficient mice defines their role in the humoral response. Nat. Immunol. 1:31–36. doi:10.1038/76882 Gururajan, M., J. Jacob, and B. Pulendran. 2007. Toll­like receptor expres ­ sion and responsiveness of distinct murine splenic and mucosal B­cell subsets. PLoS One. 2:e863. doi:10.1371/journal.pone.0000863 Haas, K.M., J.C. Poe, D.A. Steeber, and T.F. Tedder. 2005. B­1a and B­1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity. 23:7–18. doi:10.1016/j.immuni.2005.04.011 Heer, A.K., A. Shamshiev, A. Donda, S. Uematsu, S. Akira, M. Kopf, and B.J. Marsland. 2007. TLR signaling fine­tunes anti­influenza B cell responses without regulating effector T cell responses. J. Immunol. 178:2182–2191. IFN- drives FO B cell TI-2 responses | Swanson et al.